Pharmaceutical MG217 eczema cream recalled due to staphylococcal contamination

Date:

play

Ointment creams used to treat eczema and other skin conditions have been found to be contaminated with Staphylococcus aureus and have been recalled, the Food and Drug Administration announced on Tuesday, May 12.

Wisconsin-based company Pharmacal has announced a recall of its multisymptom treatment cream and skin protection eczema cream, sold under the brand name MG217, due to a potentially life-threatening risk to users.

“Use of this product can cause a variety of infections, ranging from local adverse events to severe or life-threatening adverse events,” a notice on the FDA’s website says, adding, “Patients with weakened immune systems or skin disorders, such as wounds, burns, or skin disorders, are at increased risk for serious infections.”

However, to date, Pharmacal has not received any reports of adverse events related to this recall, according to the notice.

What eczema creams are being recalled?

Touted as “hypoallergenic” and “safe for children and babies,” the cream is a skin-protective moisturizer that provides “fast and long-term relief from itching, irritation, dryness, roughness, redness, and cracking,” according to Pharmacal’s website.

Sold in 6 oz. Tube with product code 5106, UPC 012277051067, lot 1024088, expiration date November 2026.

It was sold nationwide at wholesale and retail stores, as well as online marketplaces such as Amazon.

What should customers do if they have purchased the cream?

The FDA advised consumers who purchased the product to immediately stop using it and safely dispose of it, adding that Pharmacal has notified distributors via email and is arranging the return of all recalled products.

If you have any questions regarding this recall, please contact Pharmacal by phone at 800-558-6614 or email at aimho@pharmacalway.com Monday through Friday from 8 a.m. to 5 p.m. Central Time.

You can report side effects or quality problems you experience with the use of our products to FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail, or by fax at 1-800-FDA-0178.

Meanwhile, consumers should seek immediate medical attention if they experience any problems or side effects that may be associated with the use of this product.

What is Staphylococcus aureus?

Staphylococcus aureus, also known as Staphylococcus aureus, is a type of bacteria commonly found in the nose and skin of about 30% of people, according to the U.S. Centers for Disease Control and Prevention.

Early symptoms of staph include skin reactions that resemble acne, boils, and other conditions.

Staphylococcus bacteria are mostly harmless, but in some cases they can cause infections that can be serious and fatal to some people, especially in medical settings, where people have undergone surgery, have a weakened immune system, or have a chronic illness such as diabetes or cancer. In these cases, staphylococci can cause life-threatening conditions such as blood infections, pneumonia, heart failure and stroke, bone and joint infections, and sepsis and septic shock.

Saman Shafiq is a trending news reporter for USA TODAY. Contact her at sshafiq@usatodayco.com and follow X and Instagram @saman_shafiq7.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Trump defends Ken Griffin after feud with Mamdani over wealth tax

Mamdani plans pied-a-terre taxMayor Zoran Mamdani announced plans to...

Research says rainfall patterns are abnormal and a major problem

According to one study, the world is receiving more...

Silver Price Today May 13, 2026

How much is silver worth per ounce today?As of...